We are live on ! Find out more
CCM

CAAS Capital Management Portfolio holdings

AUM $934M
1-Year Est. Return 1.45%
This Fund
S&P 500
This Quarter Est. Return
+26.63%
1 Year Est. Return
+1.45%
3 Year Est. Return
+10.99%
5 Year Est. Return
+150.62%
10 Year Est. Return
–
AUM
$10.5B
AUM Growth
+$6.2B
Cap. Flow
+$4.78B
Cap. Flow %
45.54%
Top 10 Hldgs %
28.07%
Holding
985
New
521
Increased
87
Reduced
60
Closed
171

Top Buys

Rank Stock Value
1
RPRX icon
Royalty Pharma
RPRX
+$153M
2
RUN icon
Sunrun
RUN
+$94.3M
3
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$83.8M
4
DT icon
Dynatrace
DT
+$67.2M
5
ED icon
Consolidated Edison
ED
+$56.8M

Top Sells

Rank Stock Value
1
FSLR icon
First Solar
FSLR
+$71.8M
2
TXG icon
10x Genomics
TXG
+$62.3M
3
CZR icon
Caesars Entertainment
CZR
+$60.8M
4
DNLI icon
Denali Therapeutics
DNLI
+$53.1M
5
PENN icon
PENN Entertainment
PENN
+$42M

Sector Composition

Rank Sector Weight
1 Technology 7.01%
2 Healthcare 6.25%
3 Communication Services 2.7%
4 Consumer Discretionary 2.07%
5 Financials 1.95%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
YQ
651
17 Education & Technology Group
YQ
$19.9M
$641K 0.01%
+2,500
New +$723K
MIRM icon
652
Mirum Pharmaceuticals
MIRM
$6.36B
$635K 0.01%
+36,362
New +$715K
LVS icon
653
CALL
Las Vegas Sands
LVS
$29.8B
$632K 0.01%
10,600
– –
KBH icon
654
KB Home
KBH
$3.56B
$629K 0.01%
+18,750
New +$673K
KYNB
655
PUT
Kyntra Bio
KYNB
$28M
$627K 0.01%
+676
New +$711K
RAACU
656
DELISTED
Revolution Acceleration Acquisition Corp Unit
RAACU
$625K 0.01%
+60,000
New +$622K
PLAY icon
657
Dave & Buster's
PLAY
$369M
$621K 0.01%
+20,700
New +$460K
XERS icon
658
CALL
Xeris Biopharma Holdings
XERS
$1.41B
$615K 0.01%
125,000
– –
LITE icon
659
PUT
Lumentum
LITE
$66.1B
$607K 0.01%
+6,400
New +$552K
HZAC.WS
660
DELISTED
Horizon Acquisition Corporation Warrants, each whole warrant exercisable for one Class A ordinary sh
HZAC.WS
$604K 0.01%
+416,666
New +$517K
DKS icon
661
Dick's Sporting Goods
DKS
$18B
$601K 0.01%
+10,689
New +$609K
CLVR
662
DELISTED
Clever Leaves Holdings Inc. Common Shares
CLVR
$592K 0.01%
+2,217
New +$718K
UL icon
663
Unilever
UL
$138B
$589K 0.01%
+8,667
New +$588K
GILD icon
664
PUT
Gilead Sciences
GILD
$168B
$583K 0.01%
10,000
– –
REGN icon
665
CALL
Regeneron Pharmaceuticals
REGN
$78.3B
$580K 0.01%
1,200
– –
CAMT icon
666
Camtek
CAMT
$7.07B
$578K 0.01%
+26,399
New +$505K
BLK icon
667
Blackrock
BLK
$175B
$577K 0.01%
+800
New +$531K
RUN icon
668
CALL
Sunrun
RUN
$2.63B
$576K 0.01%
+8,300
New +$515K
DCRBU
669
DELISTED
Decarbonization Plus Acquisition Corporation Unit
DCRBU
$575K 0.01%
+50,000
New +$516K
MASS icon
670
908 Devices
MASS
$347M
$570K 0.01%
+10,000
New +$584K
SHOP icon
671
CALL
Shopify
SHOP
$160B
$566K 0.01%
5,000
– –
FNV icon
672
Franco-Nevada
FNV
$42.2B
$564K 0.01%
4,500
– –
PHAT icon
673
Phathom Pharmaceuticals
PHAT
$684M
$560K 0.01%
+16,847
New +$683K
RMGBU
674
DELISTED
RMG Acquisition Corp. II Unit
RMGBU
$558K 0.01%
+50,000
New +$533K
GILD icon
675
CALL
Gilead Sciences
GILD
$168B
$553K 0.01%
9,500
– –
25 26
27
28 29

Similar funds

CIG
CCM Investment Group Northfield, Minnesota $946M AUM
TAM
Taurus Asset Management New York $986M AUM 5.04% 1-Year Est. Return
WCF
West Coast Financial Santa Barbara, California $876M AUM 5.74% 1-Year Est. Return
CHP
Cable Hill Partners Portland, Oregon $1.02B AUM 8.59% 1-Year Est. Return
SWC
Spectrum Wealth Counsel Indianapolis, Indiana $833M AUM 10.83% 1-Year Est. Return
KTA
Keeley-Teton Advisors Chicago, Illinois $825M AUM 5.4% 1-Year Est. Return
LC
Lindbrook Capital Calabasas, California $1.08B AUM 10.14% 1-Year Est. Return
SBIA
Sheaff Brock Investment Advisors Indianapolis, Indiana $1.09B AUM 14.4% 1-Year Est. Return

CAAS Capital Management's Q4 2020 Portfolio in Review

As of Q4 2020, CAAS Capital Management held 985 positions worth $10.5B, up 145% from $4.29B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

CAAS Capital Management deployed $4.78B of net new capital in Q4 2020, opening 521 new positions and adding to 87 existing holdings. Its largest new stake was Sunrun: 1,519,346 shares worth $105M.

By sector, the portfolio is most concentrated in Technology at 7% of assets, down from 7.8% a quarter earlier, followed by Healthcare and Communication Services.

On the sell side, the largest reduction was First Solar, an estimated $71.8M trimmed.

  • CAAS Capital Management's largest Q4 2020 buy was Sunrun: 1,519,346 shares worth $105M.
  • CAAS Capital Management added most to Royalty Pharma in Q4 2020, an estimated $153M increase.
  • CAAS Capital Management's biggest Q4 2020 reduction was First Solar, cutting an estimated $71.8M.
  • CAAS Capital Management fully exited 10x Genomics in Q4 2020, selling an estimated $62.3M.
  • CAAS Capital Management's ten largest holdings make up 28% of its $10.5B portfolio in Q4 2020.
  • CAAS Capital Management opened 521 new positions and closed 171 in Q4 2020.
  • CAAS Capital Management's portfolio value rose 145% quarter-over-quarter to $10.5B.

Based on CAAS Capital Management's 13F filing for Q4 2020, filed 12 Feb 2021.